Pharma BD Deal Intelligence

Hyphens Pharma Pte. Ltd. / Cassiopea S.p.A.

2022 · Licensing/Option · Pending

This deal is too recent to grade. Critic Score and Outcome Score are assigned after the announcement-week coverage settles and, for Outcome, after the 5-year post-close assessment window opens — expected 2027 at the earliest for this deal, once/if it closes.

Key facts

Related deals

See the full interactive analysis, sources & comparables →